| Follow us on Twitter |
(Nashua, NH) – In spite of decades of research and drug development, the field of cardiology has struggled to address the needs and problems of patients with compromised or diminished cardiovascular function – a population that represents the largest single treatable segment in healthcare. But new technology is laying the foundation for what may be a new paradigm in the way cardiac medicine is practiced.
For more than a decade, research teams have actively explored technologies with the capacity to regenerate damaged heart tissue as a way to restore heart function. In the last three years – armed with enabling technologies that include advances in stem cell collection, control and proliferation, recombinant protein manufacturing, and tissue engineering – a number of companies have achieved outcomes in the clinic that demonstrate varying levels of restored cardiac function in patients with diseased hearts.
More than two dozen companies are currently shepherding cell-based cardiac therapy products through various stages of development and clinical validation. Several have received FDA Orphan Status or Fast Track designation. As milestones are achieved, the interest of major pharma and biotech companies is expected to increase, setting the stage for a spike in alliance and investment activity that will help propel sector companies toward successful product and therapy commercialization.
These developments are examined in a new and comprehensive report – Branded Cellular Therapies in Cardiac Medicine: Platforms, Players and Prospects. The report concludes that several cell-based cardiac therapies will reach the market by the end of the decade, and assesses their commercial impact.
More information is available at www.applieddata.org .
About Applied Data
Applied Data Research is a healthcare therapeutics consulting firm focused on medical market strategies, product commercialization, venture development, and market research. We assist medical market participants in achieving their business objectives through the creation of detailed business development strategies, product commercialization programs, and comprehensive market and technology research and analysis.
Contact:
Greg Stone
Voice: 603-595-6225
Fax: 603-804-0466
www.applieddata.org
Source: Applied Data Research
Posted December 3rd, 2007 by gstone
